Results 21 to 30 of about 57,449 (202)

Emergency Department Buprenorphine Quality Improvement and Emergency Physician Knowledge, Attitudes, and Self-Efficacy

Western Journal of Emergency Medicine, 2023
Objective: Buprenorphine is an evidence-based treatment for opioid use disorder that is underused in the emergency department (ED). In this study we evaluated changes in emergency physician knowledge, confidence, and self-efficacy regarding buprenorphine
Michelle L. Myles, Kelli Scott, Hannah N. Ziobrowski, Sarah A. Helseth, Sara Becker, Elizabeth A. Samuels   +5 more
doaj   +1 more source

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs

Substance Abuse Treatment, Prevention, and Policy, 2022
Background and aims In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly.
Barrot H. Lambdin, David Kan, Alex H. Kral   +2 more
doaj   +1 more source

Adapting low-dose buprenorphine induction to meet patient needs: A pilot study

Drug and Alcohol Dependence Reports, 2022
Introduction: Low-dose buprenorphine induction (LDBI) has been proposed to initiate buprenorphine in patients who are taking full opioid agonists in order to limit the risk of precipitated withdrawal.
Zoe A. Karavolis, Payel J. Roy
doaj   +1 more source

A comparative study of intrathecal and epidural buprenorphine using combined spinal-epidural technique for caesarean section

Indian Journal of Anaesthesia, 2010
Neuraxial opioids provide excellent analgesia intraoperatively and postoperatively while allowing early ambulation of the patient by sparing sympathetic and motor nerves. A prospective, randomised double blind study was conducted involving 90 patients of
Shaloo Ipe, Sara Korula, Sreelatha Varma, Grace Maria George, Saramma P Abraham, Leena Rachel Koshy   +5 more
doaj   +1 more source

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men [PDF]

Addiction and Health, 2018
Background: Buprenorphine sublingual tablets are now available in Iran for opioid detoxification in clinics. Aim of the present study was to compare the efficiency of buprenorphine with buprenorphine/naloxone in short-term detoxification in a group of ...
Hassan Ziaaddini, Shima Heshmati, Maryam Chegeni, Mahboobeh Mousavi-Ramezanzade, Shahrzad Mazhari   +4 more
doaj   +1 more source

Buprenorphine for Opioid Use Disorder in the Emergency Department: A Retrospective Chart Review

Western Journal of Emergency Medicine, 2020
Introduction: Emergency care providers routinely treat patients with acute presentations and sequelae of opioid use disorder. An emergency physician and pharmacist implemented a protocol using buprenorphine for the treatment of patients with opioid ...
Kathy T. LeSaint, Brent Klapthor, Ralph C. Wang, Curtis Geier   +3 more
doaj   +1 more source

Perioperative Buprenorphine Management and Postoperative Pain Outcomes: A Retrospective Study with Evidence-Based Recommendations

International Journal of Translational Medicine
The prevalence of patients on buprenorphine therapy presenting for elective surgery has increased. Buprenorphine is a widely used medication for the management of patients with chronic pain.
Amruta Desai, Shruti Parikh, Sergio Bergese   +2 more
doaj   +1 more source

Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination [PDF]

Mental Health Clinician
Introduction: Opioid overdose deaths continue to rise despite available safe and efficacious treatments for opioid use disorder, such as buprenorphine. Whereas provider-level access to buprenorphine has improved, community pharmacy-level barriers remain,
Winter Roth, PharmD, BCPP, David Dadiomov, PharmD, BCPP   +1 more
doaj   +1 more source

Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin‐evoked dopamine release in rats

Neuropsychopharmacology Reports, 2020
Aims The United States of America is currently in an opioid epidemic. Heroin remains the most lethal opioid option with its death rate increasing by over 500% in the last decade.
Dominic P. Isaacs, Ryan P. Leman, Thomas J. Everett, Hendrick Lopez‐Beltran, Lindsey R. Hamilton, Erik B. Oleson   +5 more
doaj   +1 more source

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018

Addiction Science & Clinical Practice, 2022
Background Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis.
Kevin P. Conway, Dalia Khoury, Rainer Hilscher, Arnie P. Aldridge, Stephanie J. Parker, Gary A. Zarkin   +5 more
doaj   +1 more source